
A Regenerative Medicine Company Puts Its Off-the-Shelf Vessel Replacements to the Test in Ukraine
The Bio Report
00:00
The Human Immune System Is Not Rejecting Tissues
In over 460 patients that have gotten the h v is we've never seen a single episode of what we would call clinical rejection. These tissues are simply not rejected because we wash away parts of the tissue that the, that the human immune system might recognize what are sells. The h v is being studied in two face three trials. One is in the treatment of vascular trauma and another with kidney failure who are on hemodialysis.
Transcript
Play full episode